SCHEMBL7879547

SCHEMBL7879547

CN1CCN(c2ccccc2CCNC(=O)c2ccc(F)c3ccccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 1/20 0.48
HTR6 P50406 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HSD17B10 Q99714 1/20 0.42
SNCA P37840 1/20 0.42
DRD3 P35462 2/20 0.42
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
HCN1 O60741 1/20 0.41
SLC6A4 P31645 1/20 0.41
PDGFRA P16234 1/20 0.41
GLA P06280 1/20 0.41
CXCR5 P32302 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662366 0.82 NPC1 (0.52) KDM4EALDH1A1HPGDDRD3DRD2
SCHEMBL5160955 0.80 HTR1A (0.60) KDM4EALDH1A1HPGDHSD17B10DRD3
SCHEMBL5160839 0.79 DRD2 (0.53) DRD3DRD2DRD4SLC6A4NPC1
SCHEMBL25040904 0.79 SETD2 (0.58) KDM4EALDH1A1HPGDDRD2PDGFRA
SCHEMBL6110809 0.76 DRD2 (0.43) KDM4EALDH1A1HPGDHDAC3HDAC1
SCHEMBL6112524 0.76 HDAC3 (0.44) KDM4EALDH1A1HPGDHDAC3HDAC1
SCHEMBL5160692 0.76 HTR1A (0.59) RAB9A
SCHEMBL6110822 0.76 DRD2 (0.42) KDM4EALDH1A1HPGDHDAC3HDAC1
SCHEMBL7875925 0.74 DRD2 (0.54) ALDH1A1SNCADRD3DRD2DRD4
SCHEMBL6660894 0.74 HCN1 (0.53) KDM4EALDH1A1HPGDHSD17B10DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323229-B1 COMPOUNDS ARE USEFUL PSYCHOTHERAPEUTICS AND ARE POTENT AGONISTS AND/OR ANTAGONISTS OF THE SEROTONIN 1A (5-HT 1A) AND/OR SEROTONIN 1D (5-HT 1D) FOR TREATMENT OF HYPERTENSION, DEPRESSION, GENERALIZED ANXIETY DISORDER PFIZER INC 2001-11-27 US claimed
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
US-6323229-B1 COMPOUNDS ARE USEFUL PSYCHOTHERAPEUTICS AND ARE POTENT AGONISTS AND/OR ANTAGONISTS OF THE SEROTONIN 1A (5-HT 1A) AND/OR SEROTONIN 1D (5-HT 1D) FOR TREATMENT OF HYPERTENSION, DEPRESSION, GENERALIZED ANXIETY DISORDER PFIZER INC 2001-11-27 US disclosed
US-6197773-B1 HEADACHES; ANTIDEPRESSANTS PFIZER INC 2001-03-06 US disclosed